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Abstract.  Rat liver secretory component is synthe- 
sized as an integral membrane protein (mSC) and 
cleaved to an 80-kD soluble form (fSC) sometime dur- 
ing transceUular transport from the sinusoidal to the 
bile canalicular plasma membrane domain of hepato- 
cytes.  We have used 24-h monolayer cultures of rat he- 
patocytes to characterize the conversion of mSC to 
fSC. Cleavage of mSC in cultured hepatocytes is in- 
hibited by the thiol protease inhibitors leupeptin, an- 
tipain, and E-64, but not by other inhibitors, including 
diisopropylfluorophosphate, pepstatin, N-ethylmale- 
mide, p-chloromercuribenzoic acid, and chloroquine. 
Leupeptin-mediated inhibition of cleavage  is concentra- 
tion dependent and reversible.  In the presence or ab- 
sence of leupeptin, only 10-20%  of mSC is accessible 
at the cell surface. To characterize the behavior of sur- 
face as opposed to intracellular mSC, cell surface 
mSC was labeled with 125I by lactoperoxidase-catalyzed 
iodination at 4°C.  Cell surface ~5I-mSC was converted 
to extracellular fSC at 4°C in the absence of detect- 
able internalization. Cleavage  was inhibited by leupep- 
tin and by anti-secretory component antiserum. Cleav- 
age also occurred at 4°C after cell disruption. In 
contrast, ~25I-mSC that had been internalized from the 
cell surface was not converted to fSC at 4°C in either 
intact or disrupted cells.  Hepatocytes metabolically la- 
beled with [35S]cys also released small quantities of 
fSC into the medium at 4°C.  The properties of fSC 
production indicate that cleavage occurs on the surface 
of cultured rat hepatocytes and not intracellularly. 
Other features of the cleavage  reaction suggest that the 
mSC-cleaving protease is segregated from the majority 
of cell surface mSC, possibly within a specialized 
plasma membrane domain. 
M 
EMBRANE secretory  component  (mSC) ~ mediates 
the transcytotic movement of polymeric IgA (pIgA) 
from the sinusoidal surface of rat hepatocytes to 
the bile (reviewed in references 1 and 28). After internaliza- 
tion  from the  sinusoidal  plasma  membrane,  mSC-bound 
pIgA is initially found in the same endocytic compartments 
as the asialoglycoprotein and mannose-6-phosphate  recep- 
tors and their ligands. Segregation of pIgA-mSC complexes 
from ligands destined for lysosomes has been reported to oc- 
cur in the CURL (compartment of uncoupling receptors and 
ligands) (13). After leaving the CURL, pIgA is transported 
through the hepatocyte in uncoated vesicles that accumulate 
in the vicinity of  the bile duct (16). pIgA, still associated with 
secretory  component  (SC),  is ultimately  released  into the 
Part of this work has been published in abstract form (1986. J.  Cell.  Bio- 
chem.  10A:266.). 
1.  Abbreviations  used  in  this  paper:  DFP,  diisopropylfluorophosphate; 
E-64,  L-trans-epoxysuccinyl-leucyl-amido(4-guanidino)butane;  FI2+  chase 
medium, Ham's FI2 supplemented with 8 mM glutamine,  20 mM glucose, 
2.2  x  l0  -a M cys-HCl,  100 U/ml penicillin, and 100 mg/ml streptomycin; 
fSC, the soluble 80-kD form of secretory component that contains the bind- 
ing site for polymeric immunoglobulin A; mSC, membrane secretory com- 
ponent; NEM, N-ethylmaleimide;  PCMB, p-chloromercuribenzoic acid; 
pIgA, polymeric immunoglobulin A; SC,  secretory  component; TLCK, 
tosyl-L-lysine chloromethyl ketone. 
bile. Although the plgA found in bile is intact, the molecular 
mass of SC has decreased from ,x,120 to 80 kD (20, 40, 41). 
This reflects cleavage near the membrane-anchoring domain 
of mSC,  resulting in conversion of mSC from an integral 
membrane protein to a soluble, secreted protein (fSC) (26). 
fSC is also produced by rat hepatocytes in the absence of 
plgA, indicating that movement of mSC to the region of the 
bile canaliculus and its cleavage to yield fSC do not require 
bound plgA (29). 
It is not known at what point cleavage of mSC to fSC takes 
place during transport to the bile (1, 25, 38). The absence of 
fSC in the blood of healthy individuals  (23) suggests that 
cleavage rarely if  ever occurs on the sinusoidal surface of he- 
patocytes. If the membrane-bound domain of mSC were re- 
quired for segregation of mSC-plgA complexes from other 
ligands and receptors, conversion ofmSC to fSC is not likely 
to occur before or within the CURL. The reported absence 
of fSC  in intracellular  membranes  (20, 42)  suggests that 
mSC cleavage may occur at the bile canalicular surface itself 
or within uncoated vesicles immediately before entry of SC 
into the bile. Production of fSC, therefore, is likely to be a 
highly localized process. This suggests that the protease that 
cleaves mSC to fSC is either absent from or inactive within 
the endoplasmic reticulum, Golgi, sinusoidal plasma mem- 
brane, and endocytic vesicles through which mSC passes be- 
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thesis and processing in cultured rat hepatocytes. Primary rat hepa- 
tocyte monolayer cultures  were labeled with  [35S]cys for 30 min 
and chased in media containing excess unlabeled cysteine for up 
to 24 h. The media and cells were then separately boiled in SDS, 
immunoprecipitated with anti-SC antiserum, and analyzed by SDS 
PAGE and fluorography. Lanes 8 and 9 depict normal rabbit serum 
controls from a similar experiment. (Lanes 1-4) Anti-SC immuno- 
precipitates from the lysates of cells chased for the indicated times; 
(lanes 5-7) anti-SC immunoprecipitates  from the media of cells 
chased for the indicated times; (lane 8) cell lysate, 1-h chase, nor- 
mal rabbit serum control; (lane 9) media, 9-h chase, normal rabbit 
serum control. 
fore its arrival at its site of cleavage in the region of the bile 
canaliculus. 
We  have  used  primary  rat  hepatocytes  maintained  in 
monolayer culture to characterize the conversion of mSC to 
fSC and to determine how cleavage ofmSC is regulated. He- 
patocyte monolayers synthesize mSC and release fSC into 
the culture medium in a time-dependent fashion. Conversion 
of mSC to fSC occurs exclusively at the surface of cultured 
cells, reflecting the localization of an mSC cleaving protease 
to the plasma membrane. The protease has only limited ac- 
cess to mSC at the cell surface, indicating that the protease 
and mSC may be segregated from each other on the plasma 
membrane. This raises the possibility that the mSC-cleaving 
protease is confined to the bile canalicular domain of both 
hepatocytes in culture and whole liver. 
Materials and Methods 
Materials 
E-64  (L-trans-epoxysuccinyl-leucyl-amido(4-guanidino)butane) was  pur- 
chased from Peptide Institute, Inc. (Osaka, Japan). All other inhibitors were 
obtained from Sigma Chemical Co. (St. Louis, MO). The compositions of 
the standard tissue culture media used (L15,  DME)  were as listed in the 
Gibc,  o  catalogue (Grand Island,  NY).  Sources of other reagents are de- 
scribed elsewhere (Musil, L. S., and J. U. Baenziger, manuscript submitted 
for publication). 
Hepatocyte Culture, Labeling,  and Ii'ypsinization 
Details of the isolation and culture of the rat hepatocytes, [3~S]cys meta- 
bolic labeling of mSC, lactoperoxidase-catalyzed cell surface radioiodina- 
tiOn, and trypsin treatment of intact ceils are given elsewhere (Musil, L. S., 
and J. U. Baenziger, manuscript submitted for publication). All 4°C incuba- 
tions were conducted on ice in a 6°C cold room with hepatocyte monolayers 
chilled to 4°C on ice for 10 min before the beginning of the experiment. 
Immunoprecipitation and Quantitation of  SC 
Experiments were  terminated by addition of SDS  to  labeled  hepatocyte 
monolayers and media followed by immunoprecipitation with anti-SC an- 
tiserum as detailed elsewhere (Musil, L. S., and J. U. Baenziger, manuscript 
submitted for publication). Immunoprecipitated mSC and fSC were sepa- 
rated by SDS PAGE on 10% discontinuous gels according to Laemmli (22) 
and visualized by either fluorography ([35S]cys-labeled  samples) (4) or au- 
toradiography (125I-labeled samples) on prefogged XAR-5 film. Quantita- 
tion was performed by densitometry. The effect of  protease inhibitors of fSC 
production is presented: percent inhibition of fSC production =  [(B -  A)/ 
(B)]  x  100, where A  =  (fSC)/(mSC +  fSC) in the presence of inhibitor and 
B  =  (fSC)/(mSC +  fSC)in the absence of inhibitor. None of the inhibitors 
tested caused more than a 35 % decrease in the total labeled SC content of 
treated cells. Significant quantities of fSC were not detectable in the cell ly- 
sates under any conditions. 
Inhibitor Studies 
Concentrated stock solutions of inhibitors were prepared as follows: chy- 
mostatin, 20x in 0.1 N NaOH; 1,10  phenanthroline, 1,000x in EtOH; phe- 
nylmethylsulfonyl  fluoride (PMSF), 200x in isopropanol; diisopropylfluo- 
rophosphate  (DFP),  1:6  in  isopropanol;  pepstatin,  1,000x  in  dimethyl 
sulfoxide,  and p-chloromercuribenzoic  acid  (PCMB),  100x  in  0.1  N 
NaOH. All other inhibitors were prepared as stock solutions in distilled wa- 
ter.  Due to their lability in aqueous solutions PMSF, tosyl-L-lysine chlo- 
romethyl ketone (TLCK), DFE and N-ethylmaleimide (NEM) stock solu- 
tions  were  prepared  and  diluted  into  media  immediately  before  use. 
Hepatocyte cultures were metabolically labeled with [35S]cys for 1 h. Un- 
less otherwise indicated labeled cells were chased for 5  h  in F12÷  chase 
medium (Ham's F12 supplemented with 8 mM glutamine, 20 mM glucose, 
2.2  x  10  -4 M cys-HC1, 100 U/ml penicillin, and 100 mg/ml streptomycin) 
in the presence or absence of inhibitor. The effects of agents in stock solu- 
tions, other than the inhibitors, was assessed  on control cultures by addition 
of equivalent amounts of stock solution without inhibitor. At the end of the 
chase SC was immunoprecipitated from both the media and the cells as de- 
scribed above. 
PCMB, p-chloromercuribenzenesulfonic  acid, DFP (4-h Incubation 
at 1.0 mM), NEM, EDTA,  TLCK,  and PMSE Failure of nascent 100-kD 
[35S]cys-labeled  mSC to mature to the  105-kD form of mSC in the pres- 
ence of  these agents indicated that they prevented the transport of mSC from 
the endoplasmic reticulum to the Golgi. Monolayers labeled with [35S]cys 
for 1 h were therefore incubated for 2 h in FI2+ chase medium before addi- 
tion of these inhibitors to allow transport of the majority of [3SS]cys mSC 
to the Golgi. No detectable fSC was produced during this 2-h period. Inhibi- 
tors were added and incubations continued for either 2.5 h (NEM, EDTA, 
and TLCK) or 4 h (PCMB, p-chloromercuribenzenesulfonic acid,  1.0 mM 
DFE and PMSF). For DFP, PMSF, and TLCK the chase with inhibitor was 
carried out in F12+ chase medium. EDTA was added to cells in Ca  ++- and 
Mg++-free  Hanks'  balanced  salt  solution  (Gibco).  Chases  containing 
NEM, PCMB, or p-chloromercuribenzenesulfonic acid were conducted in 
incubation buffer (8.0 g  NaC1, 0.4 g KCI, 0.09 g  Na2HPO4.7H2O,  0.047 g 
KH2PO4, 0.097 g MgSO4, 0.4 g CaCI2.H20, and 4.76 g Hepes per 1,000 ml 
H20 adjusted to pH 7.5  with NaOH)  free of low molecular mass thiols. 
DFP (lO-min Incubation).  A  modification of the procedure used by 
Rotundo and Fambrough to inhibit acetylcholinesterase in intact chick em- 
bryo muscle cells was used (32).  Monolayers labeled with [35S]cys for I h 
were chased for 3 h in F12+ chase medium without DFP to allow transport 
of labeled mSC out of the endoplasmic reticulum. The cells were then ex- 
posed to DFP at either 1.0 or 0.1 mM in L15 medium for 10 min at room 
temperature.  DFP was subsequently removed from the cells by washing 
three times with L15 and then submerging the cultures in 500 ml of the same 
medium for 10 min before incubation at 37°C for 2  h. 
Pepstatin.  As this inhibitor has been reported to enter cells slowly (6), 
hepatocytes were  incubated  for  10  h  in pepstatin-containing DME  sup- 
plemented with  15%  fetal calf serum before labeling. Cells were then in- 
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pepstatin. The cultures were chased for 5 h in F12+ medium supplemented 
with pepstatin and 15 % fetal calf serum. 
Leupeptin  Reversal.  Leupeptin-induced inhibition of fSC generation 
was reversed at either 37 or 4°C by washing the cultures eight times with 
2  ml of leupeptin-free medium. Between the third and fourth washes the 
cells were incubated in 2 ml of this medium for 7 min to enhance dissocia- 
tion of bound leupeptin. 
Cleavage of  mSC in Disrupted Hepatocytes 
Labeled hepa~'zyte monolayers were chilled to 4°C before being scraped 
into 1 ml of ice-cold 0.25 M sucrose, 10 mM Hepes, pH 7.5. The cells were 
disrupted by  80  strokes of a  tight-fitting pestle in a  7-ml  Dounce-type 
homogenizer (Wheaton Instruments Div.,  Millville,  NJ)  and  nuclei re- 
moved by centrifugation for l0 min at 630 g. The samples were maintained 
at 4°C throughout this procedure. The postnuclear superuatant was then in- 
cubated on ice for up to 8 h. At the end of the incubation period the samples 
were boiled in 0.6% SDS and immunoprecipitated with anti-SC antiserum 
as described for the lysates from intact cells. 
Results 
Synthesis, Posttranslational  Processing, and 
Cleavage of  mSC in Cultured Primary  Rat Hepatocytes 
To demonstrate that cultured primary rat hepatocytes synthe- 
size mSC  and accurately cleave it to fSC,  rat hepatocyte 
monolayers cultured for 24 h were labeled with [35S]cys for 
30 min and chased for up to 24 h as shown in Fig.  1. Using 
rabbit anti-rat fSC antiserum, three species were immuno- 
precipitated from the cultures at various times during the 
pulse-chase:  two forms of SC  migrating with Mrs  of 100 
and 105 kD were obtained from the cell lysate (lanes 1-4) 
whereas a single species which migrated as a doublet of Mr 
'o80 kD was recovered from the medium (lanes 6 and 7). 
Precipitation of all three species was prevented by addition 
of rat bile containing fSC and did not occur when normal 
rabbit serum was substituted for the anti-SC antiserum (Fig. 
1, lanes 8 and 9). The species with an M, of 80 kD, immu- 
noprecipitated from the medium, co-migrated with fSC iso- 
lated from rat bile and had the same relative molecular mass 
as reported for fSC produced by perfused rat liver (21). In 
studies described in detail elsewhere (Musil, L. S., and J. U. 
Baenziger, manuscript submitted for publication), we have 
shown that the  100-kD  band represents newly synthesized 
mSC in the endoplasmic reticulum, which is converted to the 
105-kD form of mSC by oligosaccharide processing in the 
Golgi. All or at least a part of the 105-kD mSC is then trans- 
ported to the plasma membrane and reinternalized before be- 
ing quantitatively cleaved and released into the medium as 
the 80-kD form of fSC. Conversion of 105-kD mSC to fSC 
is  relatively slow  (tv2 13 h)  in hepatocyte monolayers, in 
contrast to the secretion of albumin and transferrin from the 
same cultures (/I/2 <1 h for albumin and between 1 and 3 h 
for transferrin). No significant quantities of the 80-kD spe- 
cies were detected in the cell lysates of cultured hepatocytes 
at any time. These results indicate that cultured rat hepato- 
cytes process mSC and cleave it to fSC in a manner qualita- 
tively similar to, albeit slower than, that of intact liver. 
Effect of  Protease Inhibitors on mSC Cleavage 
in Cultured Rat Hepatocytes 
A  variety of protease  inhibitors  were  examined for their 
effect on fSC production (Table I). Hepatocyte monolayers 
were  labeled  with  [35S]cys and  the  appearance  of  im- 
munoprecipitable [35S]cys-fSC in the medium monitored in 
the presence and absence of each inhibitor. The majority of 
protease inhibitors tested did not alter [35S]cys-mSC cleav- 
age.  This included inhibitors which, under similar condi- 
tions, have been reported to decrease other forms of pro- 
teolysis in intact cells (36).  Cleavage of mSC was not de- 
creased by either NI-hC1 or chloroquine,  which  raise the 
pH  of acidic  intracellular compartments  (34,  35),  imply- 
ing that cleavage is not dependent on an acidic environment 
within intracellular vesicles. Insensitivity of  biliary secretion 
of plgA to chloroquine has also been reported in isolated per- 
fused rat liver (46). Neither 1,10 phenanthroline nor pepsta- 
tin inhibited mSC cleavage, indicating that the protease is not 
of the metalloprotease or carboxyl classes (5, 45). 
Leupeptin, antipain, aprotinin, and E-64 significantly re- 
duced the conversion of mSC to fSC. These compounds are 
classified as thiol, and with the exception of E-64,  serine 
protease  inhibitors  (3,  44,  45).  A  10-min  treatment with 
DFP, a potent inhibitor of serine proteases that is able to in- 
hibit 100% of the intracellular acetylchlolinesterase activity 
of perfused rat liver within 5 min at 0.1 mM (15), did not 
effect fSC generation in cultured hepatocytes at either 0.1 or 
1.0  mM.  Exposure to  1 mM  DFP  for 4  h  reduced fSC 
production by 60% but also inhibited transferrin secretion. 
Thus,  extended incubation  in  DFP  had  nonspecific toxic 
effects on secretion and did not inhibit mSC cleavage selec- 
tively. This suggested that cleavage of mSC to fSC does not 
involve  a  serine  protease.  High  levels  of the  thiol  pro- 
tease-specific inhibitor E-64 (3, 14) inhibited fSC production 
without affecting transferrin secretion, supporting the possi- 
bility that the protease responsible for the conversion of  mSC 
to fSC was a thiol protease. However, other thiol-specific re- 
agents  such  as  PCMB,  p-chloromercuribenzenesulfonic 
acid, and NEM (2) did not inhibit fSC generation by intact 
cells despite having nonspecific deleterious effects on other 
cellular functions such as transferrin secretion. Thiol pro- 
teases that are insensitive to some thiol-specific inhibitors 
such as NEM and iodoacetamide have been described (37). 
The protease responsible for mSC cleavage may be similar 
in this respect. Leupeptin and E-64 were also potent inhibi- 
tors  of  [35S]cys-fSC  production  in  metabolically  labeled 
liver slices (not shown). 
Leupeptin Inhibition of  mSC Cleavage  Is Reversible 
Leupeptin and its closely related analogue antipain were the 
most effective inhibitors of mSC cleavage. Immunoprecipita- 
tion of SC from media and cell lysates of [35S]cys labeled 
hepatocytes incubated in the presence and absence of leupep- 
tin is shown in Fig.  2.  At 2.1  x  10  -4 M  (1130 ~tg/ml),  leu- 
peptin inhibited fSC production by 75 % (Fig. 2, cf. lanes 1 
and 3) but did not reduce either albumin or transferrin secretion 
(not shown), indicating that processes associated with solu- 
ble protein secretion were not significantly altered. The cell- 
associated 35S-mSC accumulated in the presence of leupep- 
tin was exclusively the mature 105-kD form (Fig. 2, lane 2). 
Inhibition of mSC cleavage by leupeptin was concentration 
dependent, reaching 50% at 8.4  ×  10  --6 M  (see Table I) as 
assessed from experiments similar to those shown in Fig. 2. 
Inhibition of fSC production plateaued at 75 % and could not 
be increased by exposing the cultures to leupeptin during the 
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Nontoxic protease inhibitors  Potentially toxic protease inhibitors 
Inhibition of 
Protease inhibitor  Concentration  fSC production*  Protease inhibitor  Concentration 
Inhibition of 
fSC production* 
M  % 
Leupeptin  1.0  x  10  ~  26  TLCK 
2.1  x  10  -4  75  +  3.4* 
4.0  x  10  -3  74  PMSF 
Antipain  2.0  x  10  -4  75  DFP 
E-64  2.8  x  10  -4  20 
2.1  x  10  -3  45 
8.4  x  10  -3  64 
1.9  x  10  -2  82 
Aprotinin  3.2  x  10  -5  50 
1.0  x  10  -4  45 
Chymostatin  2.4  x  10  -4  0 
Pepstatin  1.5  X  10  -4  0 
Chloroquine  1.0  x  10  -4  0 
NI-hC1  2.0  x  10  -2  0 
1,  10 Phenanthroline  4.4  x  10  -4  0 
Soybean trypsin inhibitor  3.0  x  10  -5  0 
Agmatine  1.0  x  10  -3  0 
M 
7.0  x  10  -5 
1.0  X  10  -3 
1.0  X  10  -4 
1.0  x  10  -3 
1.0  x  10  -3 
NEM  1.0  x  10  -3 
PCMB  1.0  x  10  -4 
p-chloromercuri-  1.0  x  10  -3 
benzenesulfonic acid 
EDTA  1.0  ×  10  -4 
% 
0 
0 
0§ 
0§ 
6011 
0 
-15 
-25 
* Hepatocytes were metabolically  labeled with [3SS]cys for 1 h and chased in the presence or absence of inhibitor. Production of fSC was quantitated  after im- 
munoprecipitation,  SDS PAGE, and fluorography. The presence of a negative number indicates enhancement  of cleavage. 
* Mean value 5: standard error of the mean from six experiments. 
§ Exposure to DFP for 10 rain. 
II Exposure to DFP for 4 h; transferrin secretion was also reduced by 60% under these conditions. 
Figure  2.  Inhibition  of  mSC 
cleavage  by  leupeptin.  Rat  he- 
patoc~tes  were  incubated  with 
[35S]cys for  1 h  and then FI2+ 
chase  medium  with  or  without 
leupeptin (2.1  ×  10-* M) for 5 h. 
At the end of the chase period SC 
was  immunoprecipitated  sepa- 
rately from the medium (M) and 
from the cell lysate (L) and ana- 
lyzed  by  SDS  PAGE  and  fluo- 
rography. (Lane 1 ) Medium with leupeptin; (lane 2) cell lysate with 
leupeptin; (lane 3) medium without leupeptin; (lane 4) cell lysate 
without leupeptin. 
labeling as well as the chase period, Thus, leupeptin inhibi- 
tion  of  mSC  cleavage  is  selective  and  concentration  de- 
pendent. 
Inhibition of mSC cleavage by leupeptin can be reversed 
by  removal  of leupeptin  as  shown  in  Fig.  3.  Hepatocyte 
monolayers were  labeled with  [35S]cys  for  1 h  and chased 
for  12  h  in the presence  of leupeptin.  After  washing  into 
leupeptin-free medium,  the  subsequent production of fSC 
was monitored. Quantitation of the results shown in Fig. 3, 
lanes  1-4 indicated that  32 %  of cell-associated  mSC  was 
released into the medium as fSC during the first 1 hour after 
leupeptin removal.  An  additional 20%  of the  [35S]cys-SC 
was cleaved to fSC between 1.0 -2.5 h of chase in leupeptin- 
Figure 3. Inhibition  ofmSC 
cleavage by leupeptin is re- 
versible. Hepatocytes were 
labeled  with  [35S]cys for 
1 h and chased for  12 h  in 
the presence of 2.1  x  10  -~ 
M  leupeptin.  Leupeptin 
was  removed  by  washing 
the cells eight times with inhibitor-free chase medium. The incuba- 
tions were continued for 5 h at 37°C in the absence of leupeptin. At 
l, 2.5,  and 5  h  the medium was removed and replaced with fresh 
chase medium. At the end of the 5-h incubation the hepatocytes 
were  lysed.  The  cell  lysate  and  individual samples  of medium 
were immunoprecipitated with anti-SC and examined by SDS PAGE 
and fluorography.  Hepatocytes were also labeled with [35S]cys for 
1 h and chased for 5 h in the absence of leupeptin to determine the 
amount of mSC  cleaved to  fSC  in 5  h  without prior exposure to 
leupeptin. (Lane 1) Medium, 0-1-h chase; (lane 2) medium, 1-2.5-h 
chase; (lane 3) medium, 2.5-5-h chase; (lane 4) cell lysate after 5 h 
of chase; (lane 5) medium, 0-5-h chase without prior exposure to 
leupeptin; (lane 6) cell lysate, 0-5-h chase without prior exposure 
to leupeptin. 
free medium and  18%  was  cleaved  in the  following 2.5-h 
period.  In control  cells  labeled  for  1  h  with  [35S]cys  and 
chased for 5 h  in the absence of leupeptin, only 28%  of the 
labeled mSC was released as fSC (Fig. 3, lanes 5 and 6). The 
amount of [35S]cys-SC (mSC plus fSC) recovered  from the 
control and leupeptin-treated cultures was approximately the 
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face proteins of cultured hepatocytes were selectively labeled with 
~25I by lactoperoxidase-catalyzed  iodination  at  4°C.  Cells  were 
washed to remove unincorporated  ~25I and maintained  in incuba- 
tion buffer at 4°C. One plate of cells was lysed immediately after 
labeling (time 0).  Another culture was incubated for 12 h at 4°C, 
during  which time the medium was removed and replaced  with 
fresh incubation buffer at 3-h intervals. A cell lysate was prepared 
from the hepatocytes  after the  12-h incubation  to determine  the 
amount of  remaining cell associated mSC. After the 12-h  incubation 
another  plate of cells was treated with trypsin before preparation 
of the cell lysate (lane 9) to demonstrate that the remaining mSC 
was still accessible at the cell surface. All medium and lysate sam- 
pies were immunoprecipitated with anti-SC and analyzed by SDS 
PAGE and  autoradiography.  Normal  rabbit  serum  controls  are 
shown and indicate that the high molecular  mass material desig- 
nated with the arrowhead in the precipitates of both media and cell 
lysates is nonspecific. One-third of the total medium and one-sixth 
of each  cell  lysate  was  used  for the  immunoprecipitates.  The 
medium  and cell  lysate lanes  are from 2- and 6-d exposures  of 
the same gel, respectively. (Lane 1 ) Medium, 0-3 h of incubation; 
(lane 2) medium,  3-6 h of incubation; (lane 3) medium,  6-9 h of 
incubation;  (lane  4)  medium,  9-12  h  of  incubation;  (lane  5) 
medium, 0-3 h of incubation,  normal rabbit serum control;  (lane 
6) cell lysate, time 0; (lane 7) cell lysate, time 0, normal rabbit se- 
rum control;  (lane 8) cell lysate after 12 h of incubation; (lane 9) 
cell lysate from cells incubated for 12 h and treated with trypsin be- 
fore lysis. 
same. The greater extent of cleavage of mSC after leupeptin 
removal as compared with control cells suggested that rever- 
sal of leupeptin inhibition was rapid and that mSC had accu- 
mulated at a  site within the hepatocyte that was late in the 
intraceUular transport pathway leading  to fSC generation. 
This  site may be analogous to the transcytotic vesicles in 
which mSC is transported from the sinusoidal plasma mem- 
brane to the bile canaliculus in vivo (16). Since conversion 
of mSC to fSC after accumulation at this site is accelerated 
when compared with newly synthesized mSC, movement of 
newly synthesized mSC to its site of cleavage may be the rate- 
limiting step in fSC generation rather than the cleavage reac- 
tion itself. 
Cellular Site of  Surface-labeled mSC Cleavage 
The rapid reversal of leupeptin-mediated inhibition of fSC 
generation suggested that cleavage of mSC was occurring at 
a  site from which leupeptin could be easily removed, such 
as  the  plasma membrane or a  vesicle population  in  rapid 
equilibrium with the cell surface. Tryptic digestion of meta- 
bolically labeled hepatocytes at 4°C indicated that roughly 
90%  of [35S]cys-mSC  was trypsin resistant and thus intra- 
cellular.  This was consistent with cell surface immunopre- 
cipitation studies which also indicated that only a small frac- 
tion  of total  cellular  mSC  was  accessible  at  the  plasma 
membrane (Musil,  L.  S.,  and J.  U. Baenziger,  manuscript 
submitted for publication),  mSC accumulated in the pres- 
Figure 5.  Effect of leupeptin 
and NEM on ~I-fSC genera- 
tion  at 4°C.  Hepatocyte  cell 
surface proteins were labeled 
with  ~25I as in Fig. 4 and the 
labeled monolayers maintained 
at 4°C  for 8 h in incubation 
buffer containing  2.1  x  10  -4 
M leupeptin (lanes I  and 2), no additions (lanes 3 and 4), or 125 
gg/ml NEM (lanes 5 and 6). Media (lanes 1, 3, and 5) and cell ly- 
sates (lanes 2, 4, and 6) were examined for SC by immunoprecipita- 
tion with anti-SC antiserum followed by SDS PAGE and autoradi- 
ography. 
ence of leupeptin was also predominantly (,,080%) intracel- 
lular.  If mSC  cleavage  occurs  intracellularly,  significant 
amounts of intracellular [35S]cys-fSC might be expected, es- 
peciaUy  after  reversal  of  leupeptin  inhibition.  Although 
small  quantities  of cell-associated  [35S]cys-fSC  were  ob- 
served after leupeptin removal (Fig. 3, lane 4) as well as in 
untreated cells (Fig. 3, lane 6), this fSC was sensitive to tryp- 
sin digestion and therefore probably extracellular. The lack 
of intracellular fSC suggested that mSC cleavage occurs on 
the cell surface rather than within intracellular vesicles. 
To examine the behavior of mSC present on the hepatocyte 
cell surface, plasma membrane proteins, including cell sur- 
face  mSC,  were  selectively  labeled  by  lactoperoxidase- 
catalyzed iodination  with L~5I at 4°C.  Immunoprecipitation 
of t25I-labeled SC yielded the 105-kD form of mSC (Fig. 4, 
lane 6). When hepatocytes were maintained at 4°C after io- 
dination,  lZSI-mSC remained completely sensitive to diges- 
tion with trypsin (Fig. 4, lane 9), confirming the surface lo- 
cation  of the  mI-mSC.  Cleavage  of mSC  at  the  plasma 
membrane was assessed by maintaining the cells under con- 
ditions that prevent internalization.  Hepatocyte monolayers 
maintained at 4°C after lactoperoxidase-catalyzed cell sur- 
face  iodination  were  able  to  cleave  L~5I-mSC and  release 
t25I-fSC into the medium at a  slow but discernable rate, as 
seen in lanes 1-4 of Fig. 4. In five independent experiments, 
an  average of 27 %  of the  ~25I-mSC was converted to  fSC 
over an 8-h period at 4°C with little net loss of total SC (mSC 
plus  fSC)  signal  during  this  time.  The  L~5I-mSC that  re- 
mained cell-associated after 12 h at 4°C was sensitive to tryp- 
sin digestion (Fig. 4, lane 9), indicating that internalization 
was effectively prevented by incubation at 4°C even for ex- 
tended periods of time. Cleavage therefore appeared to be oc- 
curring at the cell surface. The specificity of the cleavage of 
125I-mSC to ~25I-fSC is shown in Fig.  5.  Production of 125I- 
mSC at 4°C was inhibited by leupeptin (Fig. 5, lane 1 ) but 
not by NEM (Fig.  5,  lane 5) or PMSE  Since the  ~zsI-fSC 
produced at 4°C had the same electrophoretic mobility as 
metabolically labeled fSC, and cleavage was selectively in- 
hibited  by  leupeptin,  the  same  protease  appeared  to  be 
responsible for the generation of [35S]cys-fSC at 37°C  and 
125I-fSC at 4°C. 
Additional evidence that cleavage of t25I-mSC at 4°C was 
occurring on the cell surface was obtained by examining the 
ability of anti-SC antiserum to block t25I-fSC generation at 
4°C. Anti-SC antibodies would be expected to exert any in- 
hibitory effect by acting exclusively at the cell surface since 
they  should  not  enter  the  cell  at  4°C.  Fig.  6  shows  that 
anti-SC antiserum, but not normal rabbit serum, abolishes 
fSC production at 4°C. 
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generation at 4°C by anti-SC  an- 
tiserum.  Hepatocyte  cell surface 
proteins  were labeled  with ~25I as 
in Fig. 4.  Anti-SC antiserum or 
normal rabbit serum  (150 Itl/ml 
incubation buffer) was added and 
the  cells  maintained  at 4°C  for 
8 h. The medium was examined 
for  SC  by  immunoprecipitation 
with  additional  anti-SC  antise- 
rum.  Since samples  were boiled 
in SDS before immunoprecipitation  with fresh anti-SC, there is no 
detectable precipitation  due to residual  anti-SC  from the initial in- 
cubation (lane 1 ). (Lane 1) Control: medium from cells incubated 
with anti-SC was boiled in 0.6% SDS before addition  of Staphylo- 
coccus aureus. No additional  serum was added after boiling.  (Lane 
2) medium from cells incubated with anti-SC and precipitated  with 
anti-SC; (lane 3) medium from cells incubated  with normal rabbit 
serum and precipitated  with anti-SC. 
Although most forms of intracellular transport do not con- 
tinue  at  4°C  (17),  the  slow  rate  at  which  125I-fSC was 
released into the medium at 4°C raised the possibility that 
it  originated  from a  small  fraction  of t25I-mSC  that  con- 
tinued to be internalized at this temperature.  To determine 
if  cleavage  could  occur  intracellularly,  hepatocytes  were 
warmed to 37°C for 10 min to permit internalization of the 
cell surface mI-mSC and then returned to 4°C. We had pre- 
viously established that cell surface 125I-mSC became resis- 
tant to trypsin digestion after incubation at 37°C for as little 
as 10 min (Musil, L. S., and J. U. Baenziger, manuscript sub- 
mitted for publication).  As seen in Fig. 7, little 125I-fSC was 
produced during a subsequent 8-h incubation at 4°C (lane 3) 
when compared with cells that had been maintained at 4°C 
for 8 h without prior incubation at 37°C (lane 1 ). The small 
amount of t2sI-fSC produced by cells that had been warmed 
to 37°C for 10 min may have originated from the fraction of 
labeled mSC that was not internalized;  i.e.,  that which re- 
mained trypsin sensitive at the end of the 4°C incubation (cf. 
lanes 4 and 5 of Fig. 7), Thus, internalization prevented sub- 
sequent cleavage ofmSC to fSC at 4°C, indicating that cleav- 
age  of  mI-mSC  to  fSC  occurs  exclusively  on  the  cell 
surface. 
Internalization  of uSI-mSC may place  it  in  an  environ- 
ment unfavorable for cleavage due to vesicle acidification or 
altered  ion composition.  To establish  that this was not the 
case, cleavage of 12SI-mSC originating from the cell surface 
and from intracellular vesicles was compared in a broken cell 
preparation.  Cell surface mSC was labeled by lactoperoxi- 
dase-catalyzed iodination of hepatocytes at 4°C after which 
the cells were either maintained at 4°C or warmed to 37°C 
for 10 rain and then returned to 4°C. The cells were then dis- 
rupted at 4°C by Dounce homogenization and a postnuclear 
supernatant  was  prepared.  The  postnuclear  supernatants 
were incubated on ice for up to 8 h  and then examined for 
the presence of mSC and fSC by immunoprecipitation and 
SDS PAGE as shown in Fig.  8. In postnuclear supernatants 
from cells that had been maintained at 4°C, virtually all of 
the mI-mSC was converted to mI-fSC (Fig. 8, lane 1). Leu- 
peptin  inhibited  fSC  generation  in  these  lysates,  whereas 
PMSF did not (not shown). In contrast, postnuclear superna- 
tants from hepatocytes that had been warmed to 37°C for 10 
Figure 7. Internalized  125I-mSC  is not cleaved to fSC at 4°C. Hepa- 
tocyte cell  surface  proteins  were labeled  with  t25I as described in 
Fig.  4. After iodination  cells  were washed  and either maintained 
at 4°C for 10 min or warmed to 37°C for 10 min to permit internal- 
ization ofmSC present at the cell surface.  This was followed by in- 
cubation for 8 h at 4°C. Media and cell lysates were examined for 
mSC and fSC by immunoprecipitation  with anti-SC and autoradi- 
ography after SDS PAGE. Trypsin digestion  of cells  at 4°C was 
used to confirm that mSC from cells  warmed to 37°C for 10 min 
and then maintained  at 4°C was not accessible  at the cell surface, 
i.e., was intracellular.  The source of the material,  medium (M), or 
cell lysate (L), for each immunoprecipitation  is indicated.  (Lane 1 ) 
Medium  from cells  maintained  continuously at  4°C  without  a 
warmup period; (lane 2) cell lysate from cells maintained  continu- 
ously at 4°C without a warmup period; (lane 3) medium from cells 
maintained  at 4°C after 10 min at 37°C;  (lane 4) cell lysate from 
cells maintained  at 4°C after 10 min at 37°C;  (lane 5) cell  lysate 
from cells maintained  at 4°C after 10 min at 37°C and treated with 
trypsin at 4°C before lysis;  (lane 6) medium from 10-min incuba- 
tion at 37°C. 
min before disruption did not produce significant amounts of 
t25I-mSC over the 8 h of incubation at 4°C (Fig.  8, lane 3). 
Thus, the protease responsible for cleavage of mSC did not 
have  access  to  internalized  t25I-mSC  after  cell  disruption. 
Metabolically labeled  [35S]cys-mSC, >85%  of which is in- 
tracellular,  was  also  not  cleaved  after  cell  disruption  by 
Dounce homogenization (Fig. 8, lanes 4 and 5), further sup- 
porting  the  concept  that  conversion  of  mSC  to  fSC  is 
confined to the plasma membrane.  Surprisingly,  the extent 
and rate of cleavage of mSC on the plasma membrane was 
greater after homogenization than in intact cells. This can be 
Figure 8.  Conversion of mSC to 
fSC  after  cell  disruption.  Cell 
surface mSC was  selectively  la- 
beled  by  lactoperoxidase-cata- 
lyzed radioiodination,  or the total 
population  of mSC was  labeled 
metabolically  with  [35S]cys for 
5 h  followed  by  a  1-h  chase  at 
37 °C. Iodinated cells were either disrupted  immediately after label- 
ing or after a  10-min incubation  at 37°C. For both iodinated  and 
metabolically  labeled  cells disruption was carried out by Dounce 
homogenization at 4°C. A posmuclear supernatant  (PNS) was pre- 
pared from the homogenate and incubated for 0 or 8 h at 4°C before 
solubilization  by boiling  in 0.6%  SDS and  immunoprecipitation 
with anti-SC.  (Lane 1) ~25I-mSC, no warmup period, PNS treated 
with  SDS  immediately  after preparation;  (lane  2)  ~25I-mSC, no 
warmup period, PNS treated with SDS after 8-h incubation at 4°C; 
(lane 3) ~25I-mSC,  cells incubated at 37°C for 10 min, PNS treated 
with SDS after 8-h incubation at 4°C; (lane 4) [35S]cys-mSC, PNS 
treated with SDS immediately  after preparation;  (lane 5) [35S]cys- 
mSC,  PNS treated  with  SDS after incubation  for 6 h at 4°C. 
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leupeptin removal. Hepatocytes were labeled with [35S]cys for 2 h 
and chased  for 12 h in the presence  of 2.1  x  10  ~  M leupeptin. 
The ceils  were then chilled to 4°C.  (A) The cells  were washed 
repeatedly  at 4°C to remove leupeptin with the exception of one 
plate,  which was to be maintained  in leupeptin.  The incubations 
were continued at 4°C in L15 medium without any additions or in 
the presence of leupeptin, TLCK, or NEM. (Lane 1 ) Medium, no 
additions; (lane 2) cell lysate, no additions; (lane 3) medium, con- 
tinuous incubation with 2.1  x  10  -4 M leupeptin;  (lane 4) cell ly- 
sate, continuous incubation with 2.1  x  10  -4 M leupeptin; (lane 5) 
medium, 50 ltg/ml TLCK; (lane 6) cell lysate, 50 ~tg/ml TLCK; 
(lane 7) medium,  125 Itg/ml NEM; (lane 8) cell lysate, 125 Ixg/ml 
NEM. (B) The cells were treated with trypsin for 50 min at 40C, 
after which 2.5 mg/ml of soybean trypsin inhibitor and 50 I.tg/ml 
PMSF was added for 15 min. The inactivated trypsin solution was 
then removed without dislodging the monolayer, replaced with L15, 
and the incubation continued for 7 h at 4°C. After completion of 
the 4°C incubation,  media and cell lysates were immediately pre- 
pared, except for one culture, which was returned to 37°C for 1 h 
before solnhilization. Media and cell lysates were analyzed for fSC 
and mSC by immunoprecipitation  with anti-SC and SDS PAGE. 
(Lane 1 ) Medium from trypsinized cells maintained at 4°C; (lane 
2) cell lysate from trypsinized  cells maintained at 4°C;  (lane 3) 
medium from  trypsinized cells maintained at 4°C and then returned 
to 37°C for 1 h; (lane 4) cell lysate from trypsinized  ceils main- 
tained at 4°C and then returned to 37°C for 1 h. 
appreciated by comparing the results in Fig.  8  with those 
shown in Fig. 4 obtained with intact cells maintained at 4°C. 
Cell surface mSC may be more accessible to cleavage after 
cell  disruption  due  to  a  disruption  of plasma membrane 
domains. 
Cellular Site of  MetabolicaUy Labeled mSC Cleavage 
The evidence presented above strongly supports the hypothe- 
sis that mSC is cleaved exclusively at the cell surface; how- 
ever, it is possible that iodination of surface mSC may alter 
its behavior. We therefore carded out experiments similar to 
those  described  for  t25I-mSC  using  metabolically  labeled 
mSC.  Hepatocytes were labeled  with  [35S]cys and  chased 
for  11-12 h  in  the  presence  of leupeptin.  The  cells  were 
chilled to 4°C,  the leupeptin removed, and the incubation 
continued at 4°C.  In the course of a 7-h incubation at 4°C, 
detectable  levels  of  [35S]cys-fSC  were  released  into  the 
medium (Fig. 9 A, lane 1); however, the amount offSC pro- 
duced was considerably less than would have been generated 
at 37°C. The production of fSC was not inhibited by either 
TLCK or NEM (Fig. 9 A, lanes 5 and 7, respectively). No 
fSC was produced if leupeptin was not removed (Fig.  9 A, 
lane  3),  indicating  that  the  35S-fSC had  originated  from 
[35S]cys-mSC  cleaved during the 40C  incubation.  Conver- 
sion of [35S]cys-mSC  to fSC at 4°C  was also inhibited  by 
addition  of anti-SC  antiserum to  the  cells after leupeptin 
removal (not shown).  Selective destruction  of cell  surface 
mSC by trypsin digestion also prevented subsequent produc- 
tion of fSC at 4°C after leupeptin removal (Fig. 9 B, lane 1 ). 
When the trypsin-treated hepatocytes were returned to 37°C, 
however, fSC production resumed (Fig. 9 B, lane 3). Trypsin 
digestion, therefore, destroyed plasma membrane mSC but 
did  not  abolish  the  cell's  capacity  to  cleave  mSC.  Thus 
[35S]cys-mSC,  like ~25I-mSC, is converted to fSC on the cell 
surface. The limited production of [35S]cys-fSC at 4°C most 
likely reflects the low levels of [35S]cys-mSC  present on the 
plasma  membrane  and  its  accessibility  to  the  protease 
mediating cleavage. 
Discussion 
The intraceUular transport and processing of SC differs from 
that of other hepatic cell surface receptors. Although pIgA- 
mSC  complexes enter the  cell  within  the  same endocytic 
vesicles as asialoglycoproteins and lysosomal enzymes bear- 
ing mannose-6-phosphate (13), pIgA is transported to the bile 
rather than to the lysosome (33).  Unlike the transferrin re- 
ceptor and the asialoglycoprotein receptor, which are repeat- 
edly returned to the cell surface intact and reused (39), mSC 
is proteolytically cleaved to a soluble form after transcellular 
transport of a single plgA molecule. Previous studies had not 
established  if the  cleavage  of mSC  to  fSC  was  causally 
related to the trafficking of SC during transcellular transport. 
It was possible that cleavage of mSC served as an intracellu- 
lar sorting signal, directing the transport of SC to the bile 
canalicular domain by a  distinct population of vesicles, or 
that transcytosis resulted in the movement of mSC to a  site 
where cleavage to fSC could occur. In both instances it seems 
likely  that  the  protease  responsible  for  the  conversion of 
mSC to fSC would have a distinct specificity and/or cellular 
location. 
Restriction of  mSC Cleavage to the Plasma Membrane 
The data we have presented indicate that cleavage of mSC to 
fSC occurs exclusively on the cell surface of cultured rat he- 
patocytes. Internalization of mSC present at the cell mem- 
brane prevents its subsequent cleavage to fSC at4°C in either 
intact or disrupted hepatocytes. The most plausible explana- 
tion for this behavior is that internalization of mSC from the 
plasma membrane results in its segregation from the protease 
responsible for fSC production.  This suggests that the pro- 
tease is localized to the cell surface and excluded from trans- 
cytotic and other intracellular vesicles.  This segregation is 
maintained even after cell disruption, making it highly likely 
that the protease is membrane-associated rather than soluble. 
This conclusion was supported by the lack of detectable fSC- 
generating activity in medium conditioned by cultured hepa- 
tocytes. 
Distribution of  mSC and the mSC-cleaving 
Protease on the Cell Surface 
Cleavage of cell surface L~I-mSC proceeds slowly in intact 
cells at 4°C. In contrast, plasma membrane ~2~I-mSC  is rap- 
idly and quantitatively  converted to  125I-fSC when labeled 
monolayers are disrupted by Dounce homogenization at 4°C. 
This suggests that all of the mSC present on the cell surface 
is potentially cleavable and that protease activity is not a lim- 
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slower rate of mSC cleavage seen with intact cells is that the 
majority ofceU surface mSC is localized to a different region 
of the plasma membrane than the protease. Cleavage of mSC 
to fSC would then require redistribution of mSC and/or the 
protease such that they become colocalized in the same re- 
gion(s) of the plasma membrane. At 37°C cell surface mSC 
is rapidly internalized and thus separated from the protease. 
The slow time course of fSC production at 37°C in metaboli- 
cally labeled hepatocytes may reflect the time required for in- 
ternalized mSC to return to a region of the plasma membrane 
enriched in the mSC-cleaving protease. Cell surface mSC is 
not internalized at 4°C. Gradual cleavage of mSC on the cell 
surface at 4°C may be due to incomplete segregation ofmSC 
and protease on the cell surface, allowing a small amount of 
protease to gain access to mSC by lateral diffusion in the 
plane of the plasma membrane. 
Hepatocytes maintained in monolayer culture have been 
shown to form distinct sinusoidal, lateral, and bile canalicu- 
lar plasma membrane domains separated from each other by 
intercellular  junctions (10, 49). Internalized pIgA-mSC com- 
plexes appear to preferentially accumulate near, and proba- 
bly be secreted from, the bile canaliculus-like regions of 
these monolayers (12). It is possible that the protease respon- 
sible for cleavage of mSC at the plasma membrane is prefer- 
entially localized to the bile canalicular domain of cultured 
hepatocytes. In contrast, cell surface mSC may be located 
primarily  in  other  membrane  domains equivalent to  the 
sinusoidal and/or lateral plasma membrane. As noted above, 
segregation of the protease and mSC on the plasma mem- 
brane may be incomplete in cultured hepatocytes. This could 
be due to "leaky"  or partial tight  junctions at the bile canalic- 
ular domain borders (11, 18, 31), allowing limited diffusion 
of mSC and/or the mSC-cleaving protease between mem- 
brane domains in intact cells and resulting in cleavage of cell 
surface mSC at 4°C. Rapid access of the protease to mSC 
and cleavage to fSC may occur during Dounce homogeniza- 
tion due to disruption of these incomplete tight junctions. 
Definitive localization of the mSC-cleaving protease to a 
specific plasma membrane domain of hepatocytes awaits the 
generation of antibodies against the protease with which im- 
munofluorescence studies could be conducted. 
Restriction  of  the  mSC-cleaving  protease  to  the  bile 
canalicular membrane in vivo would provide a mechanism 
to confine secretion of fSC to the bile.  Using a  cell-free 
cleavage assay, we found that an activity that converts mSC 
to fSC is highly enriched in bile canalicular, but not sinusoi- 
dal plasma membranes prepared from rat liver (Musil, L. S., 
and J. U. Baenziger, manuscript in preparation). This would 
be in keeping with our hypothesized segregation of plasma 
membrane mSC and the mSC-converting protease in differ- 
ent domains. 
Characterization of  the mSC-converting  Protease 
The effect of protease inhibitors on the conversion of mSC 
to fSC suggests  that the mSC-cleaving protease is distinct 
from previously described, cell-associated proteases that are 
involved in selective posttranslational cleavage of proteins. 
Conversion of proalbumin to albumin in primary rat hepato- 
cyte cultures is reportedly not affected by leupeptin (30). 
Processing of  pro-opiocortin in lysates of rat pituitary neuro- 
intermediate lobe secretory granules is leupeptin sensitive 
but is also inhibited by pepstatin A and PCMB (24), which 
do not effect fSC production. Removal of the pro segment 
from proinsulin, proglucagon, and prosomatostatin in islet 
secretory granules is also inhibited by leupeptin; however, 
sensitivity to PCMB distinguishes the protease(s) involved in 
these reactions from the mSC-cleaving activity (8, 9).  Rat 
liver plasma membranes have been reported to contain an 
insulin-degrading endoprotease (48) and a trypsin-like pro- 
tease  (43).  The mSC-converting activity differs from the 
former enzyme in its insensitivity to PCMB (47) and from 
the latter in its resistance to DFP (43).  The data in Table I 
indicate that the enzyme responsible for the conversion of 
mSC to fSC is most likely a thiol protease. The high levels 
of E-64 required for inhibition of fSC production and the 
lack of effect of PCMB and p-chloromercuribenzenesulfonic 
acid on mSC cleavage suggest, however, that the active site 
sulfhydryl  of  the protease reacts poorly with thiol-specific in- 
hibitors when the protein is in the cell membrane. 
Mostov and co-workers have recently reported expression 
of SC in a mouse fibroblast cell line (7) and in MDCK cells 
(27) transfected with a cDNA coding for rabbit mSC. Both 
cell types cleave the rabbit mSC to a plgA-binding fragment 
that migrates with a relative molecular mass similar to that 
of rabbit milk fSC (,,070 kD) and is recovered almost exclu- 
sively from the medium.  Although the ability to convert 
mSC to a soluble, fSC-sized species is not restricted to cell 
types that normally synthesize SC, it is not known if  the same 
protease is involved nor if cleavage in transfected cells is 
confined to the cell surface. It is possible that many cell types 
possess proteases that are capable of converting mSC to an 
fSC-sized fragment but which are not the same as the hepato- 
cyte protease.  Alternatively, there  may be  a  single  fSC- 
generating protease whose physiological substrate in cells 
that do not synthesize SC is unknown. In this respect the 
mSC-cleaving protease may resemble endopeptidase-24.11, 
a  widely distributed cell surface peptidase which appears 
to  have  different biological  functions in  different tissues 
(reviewed in reference 19). In either case, our finding that 
leupeptin and E-64 inhibit fSC production in liver slices as 
well as in cultured hepatocytes makes it likely that the pro- 
tease that converts mSC to fSC in whole liver is responsible 
for fSC production in cultured hepatocyte monolayers. 
Conclusion 
We have determined that cleavage of mSC to fSC in cultured 
hepatocytes occurs  exclusively at  the  cell  surface.  Since 
cleavage ofmSC occurs after transcellular transport has been 
completed, cleavage does not appear to play a role in the in- 
tracellular trafficking or  segregation of mSC  from other 
receptors.  The enzyme responsible for the conversion of 
mSC to fSC has the properties of a membrane-bound thiol 
protease and may be confined to a specialized plasma mem- 
brane domain. Production of fSC appears to be determined 
by the localization of the mSC-cleaving protease and not by 
a change in the susceptibility of  cell surface mSC to cleavage. 
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